Intracerebroventricular administration of Shiga toxin type 2 altered the expression levels of neuronal nitric oxide synthase and glial fibrillary acidic protein in rat brains

Brain Research

Volumn 1230, Issue , 2008, Pages 320-333

  Boccolia, Javier ^a   Fabian Loidl C ^a   Lopez Costa, Juan José ^a   Creydt, Virginia Pistone ^a   Ibarra, Cristina ^a   Goldstein, Jorge ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Brain injury; Confocal immunofluorescence; GFAP; Nitric oxide; Shiga toxin 2

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN DAMAGE; BRAIN INJURY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS STRIATUM; HISTOCHEMISTRY; IMMUNOLOCALIZATION; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA; ESCHERICHIA COLI; RATTUS;

EID: 54049117140     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.07.052     Document Type: Article

References (44)

1. Barnett, N.D.P., Kaplan, A.M., Bernes, S.M., Cohen, M.L., 1995. Hemolytic uremic syndrome with particular involvement of basal ganglia and favorable outcome. Pediatr. Neurol. 12, 155-158.
2. Bolam, J.P., Hanley, J.J., Booth, P.A., Bevan, M.D., 2000. Synaptic organisation of the basal ganglia. J. Anat. 196, 527-542.
3. Castegna, A., Thongboonkerd, V., Klein, J.B., Lynn, B., Markesbery, W.R., Butterfield, D.A., 2003. Proteomic identification of nitrated proteins in Alzheimer's disease brain. J. Neurochem. 85, 1394-1401.
4. Chen, Y., Swanson, R.A., 2003. Astrocytes and brain injury. Cereb. Blood Flow Metab. 23, 137-149.
5. Deitmer, J.W., Rose, C.R., 1996. pH regulation and proton signalling by glial cells. Prog. Neurobiol. 48, 73-103.
6. Eriksson, K.J., Boyd, S.G., Tasker, R.C., 2001. Acute neurology and neurophysiology of haemolytic-uraemic syndrome. Arch. Dis. Child. 84, 434-435.
7. Exeni, R.A., 2001. Sindrome urémico hemolítico. Arch. Latin Nefr. Ped. 1, 35-56.
8. Forstermann, U., Schmidt, H.W., Pollock, J.S., Sheng, H., Mitchell, J.A., Warner, T.D., Nakane, M., Murad, F., 1991. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem. Pharmacol. 42, 1849-1857.
9. Fujii, J., Kinoshita, Y., Kita, T., Higure, A., Takeda, T., Tanaka, N., Yoshida, S., 1996. Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect. Immun. 64, 5053-5060.
10. Fujii, J., Kinoshita, Y., Yamada, Y., Yutsudo, T., Kita, T., Takeda, T., Yoshida, S., 1998. Neurotoxicity of intrathecal Shiga toxin 2 and protection by intrathecal injection of anti-Shiga toxin 2 antiserum in rabbits. Microb. Pathog. 25, 139-146.
11. Goldstein, J., Loidl, C.F., Pistone Creydt, V., Boccoli, J., Ibarra, C., 2007. Intracerebroventricular administration of Shiga toxin type 2 induces striatal neuronal death and glial alterations: an ultrastructural study. Brain Res. 1161, 106-115.
12. Guix, F.X., Uribesalgo, I., Coma, M., Munoz, F.J., 2005. The physiology and pathophysiology of nitric oxide in the brain. Prog. Neurobiol. 76, 126-152.
13. Hope, B.T., Michael, G.J., Knigge, K.M., Vincent, S.R., 1991. Neuronal NADPH diaphorase is a nitric oxide synthase. Proc. Natl. Acad. Sci., U.S.A. 88, 2811-2814.
14. Ignarro, L.J., Buga, G.M., Wood, K.S., Byrns, R.E., Chaudhuri, G., 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A. 84, 9265-9269.
15. Jacob, A., Hensley, L.K., Safratowich, B.D., Quigg, R.J., Alexander, J.J., 2007. The role of the complement cascade in endotoxin-induced septic encephalopathy. Lab. Invest. 87, 1186-1194.
16. Johannes, L., Decaudin, D., 2005. Protein toxins: intracellular trafficking for targeted therapy. Gene Ther. 16, 1360-1368.
17. Kita, E., Yunou, Y., Kurioka, T., Harada, H., Yoshikawa, S., Mikasa, K., Higashi, N., 2000. Pathogenic mechanism of mouse brain damage caused by oral infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 68, 1207-1214.
18. Lei, D.L., Yang, D.L., Liu, H.M., 1996. Local injection of kainic acid causes widespread degeneration of NADPH-d neurons and induction of NADPH-d in neurons, endothelial cells and reactive astrocytes. Brain Res. 19, 199-206.
19. Little, A.R., O'Callaghan, J.P., 2001. Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines. Neurotoxicology 22, 607-618.
20. Liu, X., Sullivan, K.A., Madl, J.E., Legare, M., Tjalkens, R.B., 2006. Manganese-induced neurotoxicity: the role of astroglial-derived nitric oxide in striatal interneuron degeneration. Toxicol. Sci 91, 521-531.
21. Lord, J.M., Roberts, L.M., Lencer, W.I., 2005. Entry of protein toxins into mammalian cells by crossing the endoplasmic reticulum membrane: co-opting basic mechanisms of endoplasmic reticulum-associated degradation. Curr. Top. Microbiol. Immunol. 300, 149-168.
22. Mallard, F., Antony, C., Tenza, D., Salamero, J., Goud, B., Johannes, L., 1998. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport. J. Cell Biol. 143, 973-990.
23. Marletta, M.A., Yoon, P.S., Iyengar, R., Leaf, C.D., Wishnok, J.S., 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27, 8706-8711.
24. Mizuguchi, M., Tanaka, S., Fujii, I., Tanizawa, H., Suzuki, Y., Igarashi, T., Yamanaka, T., Takeda, T., Miwa, M., 1996. Neuronal and vascular pathology produced by verocytotoxin 2 in the rabbit central nervous system. Acta Neuropathol. 91, 254-262.
25. Mizuguchi, M., Sugatani, J., Maeda, T., Momoi, T., Arima, K., Takashima, S., Takeda, T., Miwa, M., 2001. Cerebrovascular damage in young rabbits after intravenous administration of Shiga toxin 2. Acta Neuropathol. 102, 306-312.
26. Moncada, S., Higgs, E.A., 1991. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21, 361-374.
27. Oakes, R.S., Siegler, R.L., McReynolds, M.A., Pysher, T., Pavia, A.T., 2006. Predictors of fatality in postdiarrheal hemolytic uremic syndrome. Pediatrics 117, 1656-1662.
28. O'Brien, A.D., Kaper, J.B., 1998. Shiga toxin-producing Escherichia coli: yesterday, today, and tomorrow. In: Kaper, J.B., O'Brien, A.D. (Eds.), Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains. Am. Soc. Microbiology. Washington, DC, pp. 1-11.
29. Pacher, P., Beckman, J.S., Liaudet, L., 2007. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
30. Palmer, R.J., Ferrige, A.G., Moncada, S., 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524-526.
31. Paton, J.C., Paton, A.W., 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450-479.
32. Paxinos, G., Watson, C., 2005. The Rat Brain in Stereotaxic Coordinates, fifth edition. Elsevier Academic Press, Burlington, MA, U.S.A.
33. Pekny, M., Wilhelmsson, U., Bogestål, Y.R., Pekna, M., 2007. The role of astrocytes and complement system in neural plasticity. Int. Rev. Neurobiol. 82, 95-111.
34. Proulx, F., Seidman, E.G., Karpman, D., 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr. Res. 50, 163-171.
35. Ren, J., Utsunomiya, I., Taguchi, K., Ariga, T., Tai, T., Ihara, Y., Miyatake, T., 1999. Localization of verotoxin receptors in nervous system. Brain Res. 825, 183-188.
36. Rodrigo, J., Springall, D.R., Uttenthal, O., Bentura, M.L., Abadia-Molina, F., Riveros-Moreno, V., Martínez-Murillo, R., Polar, J.M., Moncada, S., 1994. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345, 175-221.
37. Sakuma, M., Hyakawa, N., Kato, H., Araki, T., 2008. Time dependent changes of striatal interneurons after focal cerebral ischemia in rats. J. Neural Transm. 115, 413-422.
38. Sandvig, K., van Deurs, B., 2005. Delivery into cells: lessons learned from plant and bacterial toxins. Gene Ther. 12, 865-872.
39. Sandvig, K., Garred, O., Prydz, K., Kozlov, J.V., Hansen, S.H., van Deurs, B., 1992. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358, 510-512.
40. Simonini, M.V., Camargo, L.M., Dong, E., Maloku, E., Veldic, M., Costa, E., Guidotti, A., 2006. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 103, 1587-1592.
41. Steinborn, M., Leiz, S., Rüdisser, K., Griebel, M., Harder, T., Hahn, H., 2004. CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr. Radiol. 34, 805-810.
42. Vincent, S.R., Kimura, H., 1992. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46, 755-784.
43. Walz, W., Hertz, L., 1983. Functional interactions between neurons and astrocytes. Part II: Potassium homeostasis at the cellular level. Prog. Neurobiol 20, 133-183.
44. Zhao, X., Ahram, A., Berman, R.F., Muizelaar, J.P., Lyeth, B.G., 2003. Early loss of astrocytes after experimental traumatic brain injury. Glia, 44, 140-152.